CME To Develop OTC Ferrous Derivatives For China
CME Group has entered into an agreement with Mysteel, the Chinese ferrous pricing and indexing services, to develop over-the-counter ferrous derivatives for risk management.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts